Dabigatran Etexilate 150mg Capsules, 150 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-475-60.
Published April 5, 2023 · Recall initiated: March 14, 2023
Summary
FDA records drug Class II recall D-0534-2023, published April 5, 2023 and initiated March 14, 2023. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 12,804 bottles; Lot: Lot #s: 22142448, 22142449, 22142450, Exp 5/2024; 22143845, Exp 7/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.
What to do
Voluntary: Firm initiated · Letter
Get an email if DABIGATRAN ETEXILATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DABIGATRAN ETEXILATE
- Manufacturer
- Ascend Laboratories, LLC
- Distributor
- Nationwide in the USA.
- UPC
- 0367877624600
- Lot
- Lot #s: 22142448, 22142449, 22142450, Exp 5/2024; 22143845, Exp 7/2024.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only,August 5, 2026
- FDADabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx only,August 5, 2026
- FDADabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack further packaged in a carton, Rx only,August 5, 2026
- FDADabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories,July 29, 2026
- FDADabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem LaboratoriesApril 5, 2023
- FDASSS brand and K-Fresh branded Enoki Mushrooms Packaged in clear plastic 200g containerApril 5, 2023
Questions about this recall
Was Dabigatran Etexilate 150mg Capsules, 150 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-475-60. recalled?
Yes. FDA published recall D-0534-2023 on April 5, 2023. Reported hazard: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DABIGATRAN ETEXILATE. UPC: 0367877624600.